Annual Financials for Gamida Cell Ltd.
Fiscal year is January-December. All values USD millions. |
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Sales/Revenue
|
- | - | - | - | - | |
Sales Growth |
- | - | - | - | - | |
Cost of Goods Sold (COGS) incl. D&A |
162,000 | 269,000 | 2.14M | 357,000 | 431,000 | |
COGS excluding D&A |
- | - | - | - | - | |
Depreciation & Amortization Expense |
162,000 | 269,000 | 2.14M | 357,000 | 431,000 | |
Depreciation |
162,000 | 269,000 | 2.14M | 357,000 | 431,000 | |
Amortization of Intangibles |
- | - | - | - | - | |
COGS Growth |
- | 66.05% | 696.65% | -83.34% | 20.73% | |
Gross Income |
(162,000) | (269,000) | (2.14M) | (357,000) | (431,000) | |
Gross Income Growth |
- | -66.05% | -696.65% | 83.34% | -20.73% | |
Gross Profit Margin |
- | - | - | - | - | NA |
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
SG&A Expense |
19.33M | 33.38M | 47.19M | 60.57M | 86.74M | |
Research & Development |
14.88M | 21.85M | 31.33M | 38.87M | 50.18M | |
Other SG&A |
4.45M | 11.53M | 15.86M | - | - | |
SGA Growth |
- | 72.68% | 41.39% | 28.35% | 43.20% | |
Other Operating Expense |
- | - | - | - | - | |
Unusual Expense |
(214,000) | 19.64M | (13.37M) | - | - | |
EBIT after Unusual Expense |
(19.28M) | (53.28M) | (35.96M) | - | - | |
Non Operating Income/Expense |
(11,000) | (389,000) | 1.08M | - | - | |
Non-Operating Interest Income |
330,000 | 877,000 | 1.25M | - | - | |
Equity in Affiliates (Pretax) |
- | - | - | - | - | |
Interest Expense |
54,000 | 68,000 | 790,000 | 648,000 | 2.63M | |
Interest Expense Growth |
- | 25.93% | 1,061.76% | -17.97% | 305.25% | |
Gross Interest Expense |
54,000 | 68,000 | 790,000 | 648,000 | 2.63M | |
Interest Capitalized |
- | - | - | - | - | |
Pretax Income |
(19.01M) | (52.86M) | (34.42M) | (61.57M) | (89.79M) | |
Pretax Income Growth |
- | -178.05% | 34.88% | -78.88% | -45.83% | |
Pretax Margin |
- | - | - | - | - | NA |
Income Tax |
- | 70,000 | (70,000) | - | - | |
Income Tax - Current Domestic |
- | 70,000 | (70,000) | - | - | |
Income Tax - Current Foreign |
- | - | - | - | - | |
Income Tax - Deferred Domestic |
- | - | - | - | - | |
Income Tax - Deferred Foreign |
- | - | - | - | - | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
(19.01M) | (52.93M) | (34.35M) | (61.57M) | (89.79M) | |
Minority Interest Expense |
- | - | - | - | - | |
Net Income |
(19.01M) | (52.93M) | (34.35M) | (61.57M) | (89.79M) | |
Net Income Growth |
- | -178.42% | 35.10% | -79.25% | -45.83% | |
Net Margin Growth |
- | - | - | - | - | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
(19.01M) | (52.93M) | (34.35M) | (61.57M) | (89.79M) | |
Preferred Dividends |
- | - | - | - | - | |
Net Income Available to Common |
(19.01M) | (52.93M) | (34.35M) | (61.57M) | (89.79M) | |
EPS (Basic) |
(0.78) | (10.53) | (1.17) | (1.41) | (1.52) | |
EPS (Basic) Growth |
- | -1,250.40% | 88.93% | -20.77% | -7.63% | |
Basic Shares Outstanding |
24.22M | 5.03M | 29.46M | 43.73M | 59.25M | |
EPS (Diluted) |
(0.78) | (10.53) | (1.69) | (1.41) | (1.52) | |
EPS (Diluted) Growth |
- | -1,250.40% | 83.91% | 16.90% | -7.63% | |
Diluted Shares Outstanding |
24.22M | 5.03M | 29.66M | 43.73M | 59.25M | |
EBITDA |
(19.33M) | (33.38M) | (47.19M) | (60.57M) | (86.74M) | |
EBITDA Growth |
- | -72.68% | -41.39% | -28.35% | -43.20% | |
EBITDA Margin |
- | - | - | - | - | NA |